Dr. Lal Pathlabs
- Advice
- Hold
Dr. Lal Pathlabs Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Dr. Lal Pathlabs
Start SIPDr. Lal Pathlabs Investment Rating
-
Master Rating:
-
Dr Lal Pathlabs has an operating revenue of Rs. 2,016.90 Cr. on a trailing 12-month basis. An annual revenue de-growth of -4% needs improvement, Pre-tax margin of 17% is great, ROE of 14% is good. The company has a reasonable debt to equity of 5%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 200DMA and close to its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 60 which is a FAIR score but needs to improve its earnings, a RS Rating of 29 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 151 indicates it belongs to a poor industry group of Medical-Services and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 431 | 428 | 467 | 439 | 415 |
| Operating Expenses Qtr Cr | 315 | 324 | 337 | 330 | 310 |
| Operating Profit Qtr Cr | 116 | 104 | 130 | 109 | 105 |
| Depreciation Qtr Cr | 21 | 21 | 21 | 19 | 22 |
| Interest Qtr Cr | 8 | 8 | 10 | 8 | 11 |
| Tax Qtr Cr | 27 | 22 | 28 | 22 | 20 |
| Net Profit Qtr Cr | 71 | 62 | 79 | 80 | 65 |
Dr. Lal Pathlabs Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 8
- Bearish Moving Average
- ___
- 8
- 20 Day
- ₹1999.94
- 50 Day
- ₹1972.27
- 100 Day
- ₹2017.29
- 200 Day
- ₹2155.14
- 20 Day
- ₹2000.11
- 50 Day
- ₹1927.01
- 100 Day
- ₹1969.69
- 200 Day
- ₹2206.38
Dr. Lal Pathlabs Resistance and Support
| Resistance | |
|---|---|
| First Resistance | ₹2040.94 |
| Second Resistance | ₹2076.52 |
| Third Resistance | ₹2097.04 |
| RSI | 54.76 |
| MFI | 56.83 |
| MACD Single Line | 28.12 |
| MACD | 25.33 |
| Support | |
|---|---|
| First Resistance | ₹1984.84 |
| Second Resistance | ₹1964.32 |
| Third Resistance | ₹1928.74 |
Dr. Lal Pathlabs Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 175,303 | 8,964,995 | 51.14 |
| Week | 140,610 | 6,849,113 | 48.71 |
| 1 Month | 216,170 | 6,636,418 | 30.7 |
| 6 Month | 226,311 | 7,153,688 | 31.61 |
Dr. Lal Pathlabs Result Highlights
Dr. Lal Pathlabs Synopsis
NSE-Medical-Services
Dr. Lal Pathlabs Ltd is involved in the business activities of Other human health activities. Company’s Total Operating Revenue is Rs. 1769.00 Cr. and Equity Capital is Rs. 83.40 Cr. for the Year ended 31/03/2023. Dr. Lal Pathlabs Ltd. is a Public Limited Listed company incorporated on 14/02/1995 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is L74899DL1995PLC065388 and registration number is 065388.| Market Cap | 16,809 |
| Sales | 1,766 |
| Shares in Float | 3.75 |
| No of funds | 282 |
| Yield | 0.6 |
| Book Value | 9.95 |
| U/D Vol ratio | 1.2 |
| LTDebt / Equity | 5 |
| Alpha | -0.02 |
| Beta | 0.47 |
Dr. Lal Pathlabs
| Owner Name | Mar-23 | Dec-22 | Sep-22 | Jun-22 |
|---|---|---|---|---|
| Promoters | 55.03% | 55.05% | 55.05% | 55.05% |
| Mutual Funds | 3.26% | 2.71% | 2.76% | 2.83% |
| Insurance Companies | 2.28% | 2.37% | 2.33% | 2.46% |
| Foreign Portfolio Investors | 23.06% | 23.8% | 23.26% | 22.37% |
| Financial Institutions/ Banks | ||||
| Individual Investors | 9.5% | 9.02% | 8.23% | 10.44% |
| Others | 6.87% | 7.05% | 8.37% | 6.85% |
Dr. Lal Pathlabs Management
| Name | Designation |
|---|---|
| Brig.(Hony) Dr. Arvind Lal | Executive Chairman |
| Dr. Om Prakash Manchanda | Managing Director |
| Dr. Vandana Lal | Executive Director |
| Mr. Rahul Sharma | Non Executive Director |
| Mr. Anoop Mahendra Singh | Independent Director |
| Mr. Sunil Varma | Lead Independent Director |
| Mr. Harneet Singh Chandhoke | Independent Director |
| Dr. Saurabh Srivastava | Independent Director |
| Mrs. Somya Satsangi | Independent Director |
| Dr. Archana Lal Erdmann | Non Executive Director |
Dr. Lal Pathlabs Forecast
Price Estimates
Dr. Lal Pathlabs Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2023-05-11 | Audited Results & Final Dividend | |
| 2023-02-02 | Quarterly Results | |
| 2022-11-08 | Quarterly Results | |
| 2022-07-28 | Quarterly Results & Interim Dividend | |
| 2022-05-17 | Audited Results & Final Dividend |
| Date | Purpose | Remarks |
|---|---|---|
| 2022-08-09 | INTERIM | Rs.6.00 per share(60%)Interim Dividend |
| 2022-06-23 | FINAL | Rs.6.00 per share(60%)Final Dividend |
| 2021-08-22 | INTERIM | Rs.6.00 per share(60%)Interim Dividend |
| 2021-07-22 | FINAL | Rs.8.00 per share(80%)Final Dividend |
| 2021-02-10 | INTERIM | Rs.6.00 per share (60%) Second Interim Dividend |
Dr. Lal Pathlabs FAQs
What is Share Price of Dr. Lal Pathlabs ?
Dr. Lal Pathlabs share price is ₹2015 As on 04 June, 2023 | 03:10
What is the Market Cap of Dr. Lal Pathlabs ?
The Market Cap of Dr. Lal Pathlabs is ₹16808.6 Cr As on 04 June, 2023 | 03:10
What is the P/E ratio of Dr. Lal Pathlabs ?
The P/E ratio of Dr. Lal Pathlabs is 70.3 As on 04 June, 2023 | 03:10
What is the PB ratio of Dr. Lal Pathlabs ?
The PB ratio of Dr. Lal Pathlabs is 9.9 As on 04 June, 2023 | 03:10